Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Patients with obesity achieved significant weight loss and cardiometabolic benefits with oral orforglipron — offering a potential alternative to injectable GLP-1 receptor agonists.
Offering free-of-charge in-hospital influenza vaccination improves survival and reduces changes of readmission in patients with advanced heart failure, according to a large cluster-randomized trial across hospitals in China.
A study challenges previous assumptions that the brain’s body map undergoes reorganization after limb amputation, finding that it remains remarkably stable — with implications for brain–computer interfaces and the treatment of phantom limb pain.
A study of over 1.2 million children found no links between aluminum-adjuvanted childhood vaccines and over 50 chronic diseases, including neurological, autoimmune and allergic conditions.
The recent defunding of USAID could lead to more than 14 million deaths, mostly in low- and middle-income countries, including 4.5 million child deaths — according to a study combining retrospective and forecasting analyses.
Long seen a ‘holy grail’ of transplant research, a first-in-human, single case study marks a step toward immunosuppression-free islet transplantation in patients with diabetes.
A 2-year randomized study shows that a holistic lifestyle intervention — integrating diet and cardiovascular monitoring with physical, social and cognitive activities — can improve cognition in older adults at risk of dementia.
A new analysis shows that more-permissive state-level firearm laws have contributed to thousands of excess firearm-related child deaths, while a few states enacting stricter laws have seen these death rates decrease.
For women carrying pathogenic mitochondrial DNA variants, a novel technique — involving transfer of their nuclear DNA to an enucleated donor egg — resulted in successful pregnancies and healthy children.
A prospective implementation study shows how a low-cost, swallowable capsule sponge could be used for regular monitoring and risk stratification in people with Barrett’s esophagus, offering a minimally invasive alternative to endoscopy.
Merging synthetic organic chemistry and biotechnology, researchers have engineered Escherichia coli that can synthesize small molecules (including paracetamol) from a plastic waste product.
Greater diversity of dietary flavonoid intake correlated with reduced all-cause mortality risk and chronic disease incidence among UK Biobank participants.
Analysis of national survey data reveals large declines in self-reported mental well-being among female parents, which suggests that maternal mental health should be a focal point of public health efforts.
Taking part in a structured exercise program after adjuvant therapy reduced the risk of colon cancer recurrence by 28% in a phase 3 trial — highlighting a powerful strategy for improving recovery and survival.
Researchers develop a personalized base-editing therapy within 6 months for a newborn with a rare genetic disease — using rapid workflow that could be customized to other patients too.
GLP-1 receptor agonist semaglutide significantly outperformed placebo in an ongoing phase 3 trial, showing reductions in steatohepatitis and liver fibrosis, in addition to cardiometabolic benefits.
Researchers studied the antibody library of a venom-immune person with extensive snakebite exposure — and generated a three-agent, broadly neutralizing cocktail that protected mice against venoms from high-priority species.
In a phase 2 trial, complete responses to neoadjuvant dostarlimab allowed most patients with early-stage solid tumors to avoid surgery, which allowed preservation of affected organs.
Three translational studies reveal elevated mitochondrial metabolism as a driver of age-related clonal hematopoiesis and suggest that targeting this process — for example, with metformin — could reduce the risk of associated diseases.